The synthesis of 19-norandrostenedione from dehydroepiandrosterone in equine placenta is inhibited by aromatase inhibitors 4-hydroxyandrostenedione and fadrozole.

The study focused on the production of 19-norandrostenedione from another compound dehydroepiandrosterone in the placenta of horses. However, it was found that the production was halted by the presence of certain substances known as aromatase inhibitors specifically, 4-hydroxyandrostenedione and fadrozole.

Methodology and Results

• The researchers performed the experiment in vitro, implying that the experiment was performed outside of a living organism. In this case, the researchers used placental tissue from fully-developed horses.
• The steroidal hormone dehydroepiandrosterone (DHEA) was used as a precursor substance. DHEA is naturally produced in the body and plays a crucial role in the creation of male and female sex hormones. In this experiment, DHEA was used to produce 19-norandrostenedione, another type of steroid hormone.
• Throughout the process, the researchers noticed that the production of 19-norandrostenedione was interrupted when two specific aromatase inhibitors — 4-hydroxyandrostenedione and fadrozole — were present.
• Aromatase inhibitors are substances that prevent aromatase, an enzyme responsible for a key step in the production of estrogen, from functioning. Specifically, 4-hydroxyandrostenedione and fadrozole are known to inhibit aromatase.

Implications and Conclusions

• These findings suggest that the synthesis of 19-norandrostenedione in equine placenta is aromatase-dependent. Considering that 4-hydroxyandrostenedione and fadrozole are aromatase inhibitors, it seems that the presence of aromatase is vital for the synthesis of 19-norandrostenedione.
• The results of the study could have potential significance in veterinary or biological science, impacting our understanding of hormonal changes in horses during gestation or hormone regulation in other equine physiological or pathological processes.